What is the primary objective of PCI DSS?

The primary objective of PCI DSS is to protect cardholder data (CHD) and sensitive authentication data (SAD) by establishing 12 requirements across six control objectives for organizations that store, process, or transmit payment card account data. Managed by the PCI Security Standards Council (PCI SSC) since 2006, it mandates secure networks, data protection, vulnerability management, access controls, monitoring, and policies to reduce fraud and breach risks.

Who is legally or professionally required to comply with PCI DSS?

All merchants and service providers that store, process, or transmit cardholder data (CHD) or sensitive authentication data (SAD), or whose systems connect to or impact the cardholder data environment (CDE), must comply with PCI DSS. This includes all entities handling Primary Account Number (PAN) via any payment channels; levels 1-4 for merchants (based on transaction volume) and two levels for service providers determine validation rigor via acquiring banks and card brands.

Does PCI DSS require an external audit or third-party certification?

PCI DSS requires external validation for higher-risk entities, including QSA-conducted Reports on Compliance (ROC) for Level 1 merchants/service providers and quarterly Approved Scanning Vendor (ASV) vulnerability scans. Lower levels use Self-Assessment Questionnaires (SAQs) like SAQ A/D, but all need Attestations of Compliance (AOC); no formal "certification" exists, but non-compliance risks contractual penalties.

How often should an assessment for PCI DSS be performed?

PCI DSS assessments must be performed annually, with ongoing validations including quarterly external ASV scans, quarterly internal vulnerability scans, annual penetration testing, and semi-annual firewall rule reviews. The Assess-Repair-Report cycle ensures continuous compliance, with scope reviews at least annually and after significant changes.

What are the consequences of non-compliance with PCI DSS?

Non-compliance with PCI DSS results in contractual penalties from card brands and acquirers, including fines up to $100,000 per month, increased transaction fees, liability for fraud losses, and potential loss of card-processing privileges. Breaches amplify costs (avg. $37/record), plus legal fees and reputational damage; 47.5% of interim-compliant entities fail to maintain controls.

An PCI DSS be mapped to other international frameworks?

PCI DSS can be mapped to other international frameworks to support integrated compliance programs. Its 12 requirements align with common controls in various standards, enabling gap analysis and shared evidence for multi-framework adherence.

What is the first step to begin implementing PCI DSS?

The first step to implement PCI DSS is to define and document the Cardholder Data Environment (CDE) through data flow diagrams and asset inventories to accurately scope CHD/SAD locations and connected systems. This enables segmentation, gap analysis, and selection of appropriate SAQ/ROC pathways.

What is the primary objective of GMP?

GMP establishes minimum standards for manufacturing controls to ensure products are consistently produced and controlled according to quality specifications. It prevents contamination, mix-ups, mislabeling, and variability through the “5 Ps”: People, Products, Procedures, Processes, Premises. Rooted in tragedies like the 1937 Elixir Sulfanilamide incident (over 100 deaths from untested solvent), GMP mandates preventive systems including validated processes, independent quality oversight, and documentation rather than end-product testing alone (FDA 21 CFR Parts 210/211; EU EudraLex Volume 4).

Who is legally or professionally required to comply with GMP?

Manufacturers of pharmaceuticals, biologics, APIs, and related products in regulated jurisdictions must comply with GMP. This includes FDA 21 CFR Parts 210/211 for U.S. drug products, EU GMP (EudraLex Volume 4) for medicinal products with Qualified Person (QP) batch certification (Annex 16), and WHO GMP for global baselines. Contract manufacturers (CMOs), suppliers, and sites exporting to these markets are accountable, with sponsors retaining oversight via quality agreements (ICH Q7 for APIs).

Does GMP require an external audit or third-party certification?

GMP compliance is verified through regulatory inspections, not mandatory third-party certification. FDA conducts unannounced inspections under 21 CFR Parts 210/211, issuing Form 483 observations or Warning Letters. EU authorities enforce via national inspectorates per EudraLex Volume 4, PIC/S harmonizes practices. Internal audits and self-inspections are required (EU Chapter 1), with WHO GMP emphasizing ongoing verification; MRAs enable mutual recognition without duplicate audits.

How often should an assessment for GMP be performed?

GMP assessments via internal audits and self-inspections must occur at planned intervals, typically annually or risk-based. FDA expects ongoing Quality Control Unit reviews (21 CFR §211.22) and periodic product quality reviews (§211.180(e)). EU GMP mandates regular internal audits (Chapter 1, since 31 Jan 2013) and management reviews (ICH Q10). Requalification follows change/maintenance triggers; environmental monitoring and CAPA trending provide continuous assessment.

What are the consequences of non-compliance with GMP?

Non-compliance triggers regulatory actions including Warning Letters, import alerts, recalls, fines, and production halts. FDA enforces via Form 483s, seizures, and consent decrees (21 CFR violations); EU issues Statements of Non-Compliance affecting QP certification. Historical cases like Elixir Sulfanilamide led to deaths and law reforms; modern penalties include multimillion-dollar remediation, market exclusion, and criminal liability for adulteration.

An GMP be mapped to other international frameworks?

GMP can be mapped to other international frameworks, such as ISO 9001, to support integrated compliance programs. Its requirements align with common quality management controls, enabling gap analysis and shared evidence for multi-framework adherence.

What is the first step to begin implementing GMP?

Conduct a comprehensive gap analysis against applicable regulations like FDA 21 CFR Parts 210/211 or EU EudraLex Volume 4. Develop a Validation Master Plan (VMP) defining scope, risks (ICH Q9), and timelines for qualification (DQ/IQ/OQ/PQ), establishing executive sponsorship and cross-functional governance to prioritize remediation.

Standards Comparison

PCI DSS vs GMP

PCI DSS

Mandatory

2022

Industry standard protecting payment cardholder data globally

GMP

Mandatory

1963

Global standards for manufacturing quality and safety controls

Quick Verdict

PCI DSS secures payment card data for merchants worldwide via contractual controls, while GMP enforces manufacturing quality for pharmaceuticals through regulatory inspections. Companies adopt PCI DSS to process cards compliantly; GMP to ensure safe drugs and avoid recalls.

Payment Security

PCI DSS

Payment Card Industry Data Security Standard

Cost

€€€€

Complexity

Medium

Implementation Time

6-12 months

Key Features

12 requirements across 6 control objectives protecting CHD
300+ granular sub-requirements with testing procedures
Contractual enforcement by payment brands and banks
Levels-based validation from SAQ to QSA ROC
CDE scoping and segmentation reduce compliance scope

Manufacturing Quality

GMP

Good Manufacturing Practice (GMP)

Cost

€€€

Complexity

Medium

Implementation Time

18-24 months

Key Features

Risk-based quality management (QRM) integration
Process and equipment validation (IQ/OQ/PQ)
Independent quality unit oversight and release
Comprehensive documentation and data integrity (ALCOA+)
Personnel training, hygiene, and facility controls

Detailed Analysis

A comprehensive look at the specific requirements, scope, and impact of each standard.

PCI DSS Details

What It Is

PCI DSS (Payment Card Industry Data Security Standard) is an industry framework for securing payment card data. Managed by the PCI Security Standards Council, it mandates technical and operational controls to protect cardholder data (CHD) and sensitive authentication data (SAD) for merchants and service providers handling Visa, Mastercard, etc. It uses a control-based approach with prescriptive requirements.

Key Components

12 requirements organized into 6 control objectives (e.g., secure networks, vulnerability management, access controls).
Over 300 sub-requirements and testing procedures.
Built on Assess-Repair-Report cycle.
Compliance via SAQ (self-assessment) or ROC (QSA audit), with levels based on transaction volume.

Why Organizations Use It

Contractual mandate from payment brands; non-compliance risks fines, processing bans.
Reduces breach costs ($37/record avg.), builds customer trust.
Enhances risk management, fraud prevention.
Competitive edge via compliance badges.

Implementation Overview

Scope CDE, gap analysis, remediate controls, validate.
Applies to all card-handling entities globally.
Ongoing: quarterly scans, annual tests; v4.0 adds customized approaches.

GMP Details

What It Is

Good Manufacturing Practice (GMP) is a regulatory framework establishing minimum standards for manufacturing controls in pharmaceuticals, biologics, and related sectors. It ensures products are consistently produced to quality criteria through preventive systems, emphasizing risk-based approaches like Quality Risk Management (QRM) across materials, processes, facilities, and records.

Key Components

Core pillars: 5 Ps (People, Premises, Processes, Procedures, Products)
Elements include quality systems (PQS), validation, documentation (SOPs, batch records), personnel training, facility controls, supplier oversight, CAPA, and audits
Built on ICH Q9/Q10, FDA 21 CFR 211, EU EudraLex Volume 4
Compliance via inspections, no central certification but enforceable regionally

Why Organizations Use It

Meets legal mandates in regulated markets, prevents recalls/liability
Enhances supply reliability, market access, operational efficiency
Builds stakeholder trust, reduces contamination/mix-up risks

Implementation Overview

Phased: gap analysis, QMS design, validation (IQ/OQ/PQ), training, audits
Applies to pharma/biologics manufacturers globally; scales by size/risk
Involves internal audits, regulatory inspections (FDA, EMA, WHO)

Key Differences

Aspect	PCI DSS	GMP
Scope	Protects cardholder data storage, processing, transmission	Manufacturing controls for drugs, biologics, facilities, processes
Industry	Payment card merchants, service providers globally	Pharmaceuticals, biologics, medical devices, food regionally
Nature	Contractual standard, enforced by card brands	Regulatory law, enforced by FDA, EMA via inspections
Testing	Quarterly ASV scans, annual pentests by QSAs	Process validation, equipment qualification, internal audits
Penalties	Fines, loss of card processing privileges	Warning letters, recalls, manufacturing halts, seizures

Scope

PCI DSS

Protects cardholder data storage, processing, transmission

GMP

Manufacturing controls for drugs, biologics, facilities, processes

Industry

PCI DSS

Payment card merchants, service providers globally

GMP

Pharmaceuticals, biologics, medical devices, food regionally

Nature

PCI DSS

Contractual standard, enforced by card brands

GMP

Regulatory law, enforced by FDA, EMA via inspections

Testing

PCI DSS

Quarterly ASV scans, annual pentests by QSAs

GMP

Process validation, equipment qualification, internal audits

Penalties

PCI DSS

Fines, loss of card processing privileges

GMP

Warning letters, recalls, manufacturing halts, seizures

Frequently Asked Questions

Common questions about PCI DSS and GMP

PCI DSS FAQ

GMP FAQ

You Might also be Interested in These Articles...

Top 10 Reasons ISO 27701 is the Ultimate Privacy Boost for Your ISO 27001 ISMS in 2025

Extend ISO 27001 with ISO 27701 for ultimate privacy governance amid GDPR & AI regs. Discover top 10 advantages like integrated audits to future-proof your ISMS

Using CIS Controls v8.1 as a ‘Compliance On-Ramp’: Map One Security Program to NIST CSF, ISO 27001, PCI DSS, and NIS2

Use CIS Controls v8.1 as your compliance on-ramp. Map one security program to NIST CSF, ISO 27001, PCI DSS, and NIS2 without duplicating work via practical mapp

The Tool Landscape for Reaching and Maintaining ISO 27701 Compliance

Discover the top tools for ISO 27701 compliance. Compare functionality, complexity, costs, and benefits to choose the best solution for your privacy program. Ac

Run Maturity Assessments with GRADUM

Transform your compliance journey with our AI-powered assessment platform

Assess your organization's maturity across multiple standards and regulations including ISO 27001, DORA, NIS2, NIST, GDPR, and hundreds more. Get actionable insights and track your progress with collaborative, AI-powered evaluations.

100+ Standards & Regulations

AI-Powered Insights

Collaborative Assessments

Actionable Recommendations

Explore More Comparisons

See how PCI DSS and GMP compare against other standards

Other PCI DSS Comparisons

Other GMP Comparisons

What It Is

Key Components

12 requirements organized into 6 control objectives (e.g., secure networks, vulnerability management, access controls).

Over 300 sub-requirements and testing procedures.

Built on Assess-Repair-Report cycle.

Compliance via SAQ (self-assessment) or ROC (QSA audit), with levels based on transaction volume.

What It Is

Key Components

Core pillars: 5 Ps (People, Premises, Processes, Procedures, Products)

Elements include quality systems (PQS), validation, documentation (SOPs, batch records), personnel training, facility controls, supplier oversight, CAPA, and audits

Built on ICH Q9/Q10, FDA 21 CFR 211, EU EudraLex Volume 4

Compliance via inspections, no central certification but enforceable regionally

Aspect

PCI DSS

GMP

Scope

Protects cardholder data storage, processing, transmission

Manufacturing controls for drugs, biologics, facilities, processes

Industry

Payment card merchants, service providers globally

Pharmaceuticals, biologics, medical devices, food regionally

Nature

Contractual standard, enforced by card brands

Regulatory law, enforced by FDA, EMA via inspections

Testing

Quarterly ASV scans, annual pentests by QSAs

Process validation, equipment qualification, internal audits

Penalties

Fines, loss of card processing privileges

Warning letters, recalls, manufacturing halts, seizures